来自多中心匹配/嵌套病例控制研究的分类生物标志物的统计方法
Yujie Wu1, Xiao Wu2, Mitchell H Gail3
1Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA.
ArXiv
|July 30, 2025
概括
这项研究引入了一种新的统计方法,用于准确分析来自多项研究的生物标记数据,解决测量错误. 这种方法确保了流行病学研究的可靠结果,特别是了解结直肠癌等疾病风险.
科学领域:
- 流行病学研究是流行病学研究.
- 生物标志物的分析分析.
- 统计建模 统计建模
背景情况:
- 聚合分析增加了研究能力,但面临的挑战是研究中的生物标志物的系统测量错误.
- 直接汇集未校准的生物标记数据可能会导致偏差的回归参数估计.
- 解决研究/试验/实验室间的变化对于准确的聚合分析至关重要.
研究的目的:
- 提出一种基于概率的统计方法,用于评估聚合数据中的生物标志物-疾病关系.
- 为了考虑到研究特定的校准过程带来的不确定性.
- 在聚合生物标志物研究中为回归参数提供有效的差异估计.
主要方法:
- 开发了一种基于概率的方法,用于匹配/嵌套病例控制研究中的分类生物标志物.
- 提出了一个三明治差异估计器来解决校准不确定性.
- 进行了广泛的模拟研究,以评估各种条件下的方法性能.
主要成果:
- 拟议的方法有效地评估了聚合数据中的生物标志物-疾病关系.
- 三明治差异估计器提供了有效的非对称差异,考虑到校准不确定性.
- 模拟研究证实了该方法的有限样本性能.
结论:
- 开发的统计方法可以更准确,更可靠地分析聚合的生物标志物数据.
- 这种方法对于减轻协作流行病学研究中的测量变异性引起的偏差至关重要.
- 这种方法成功地用结直肠癌和维生素D联合项目来说明.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Statistical Methods for Analyzing Epidemiological Data
537
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
537
Strategies for Assessing and Addressing Confounding
156
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
156
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Hazard Ratio
251
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
251
The Mantel-Cox Log-Rank Test
568
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
568


